[Clinical chemical parameter changes in patients with liver metastases].
Certain biochemical serum parameters: GOT, GPT, LAP, HK, AP and Regan isoenzyme, GGTP, CE, ESR, Weltman test, thymol test, serum bilirubin and urine urobilogen were determined in 39 patients with different localization of malignant processes in the abdominal cavity (stomach, large intestines, pancreas, ovaries). The patients were subdivided into two groups, depending on the presence or absence of liver metastases, confirmed at laparatomy, laparascopy or necropsy material examination. The results revealed that in patients with liver metastases AP, CE, GOT, GGTP, ESR and Weltman test are most commonly and simultaneously abnormal. In patients without liver metastases, those indices are also changed but to a lesser degree, whereas LAP and Regan isoenyzme are with elevated activity in a higher per cent of these cases, than in the patients with liver metastases, being in unison with literature data. The determination of the above biochemical parameters could direct the clinicist to the presence of liver metastases but the more reliable diagnostic methods as laparascopy and laparatomy cannot be substituted for.
D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D002277:Carcinoma / Q000175:diagnosis; D002802:Cholinesterases / Q000097:blood; D004796:Clinical Enzyme Tests; D006593:Hexokinase / Q000097:blood; D006801:Humans; D007527:Isoenzymes / Q000097:blood; D007931:Leucyl Aminopeptidase / Q000097:blood; D008113:Liver Neoplasms / Q000175:diagnosis*; D009362:Neoplasm Metastasis; D014558:Urobilinogen / Q000652:urine; D005723:gamma-Glutamyltransferase / Q000097:blood
D007527:Isoenzymes; D014558:Urobilinogen; D005723:gamma-Glutamyltransferase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D006593:Hexokinase; D002802:Cholinesterases; D000469:Alkaline Phosphatase; D007931:Leucyl Aminopeptidase; D001663:Bilirubin
Promeni v niakoi kliniko-khimichni parametri pri bolni s chernodrobni metastazi.